TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06295094: The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.

Sponsor: Odense University Hospital · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 264 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT06295094 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06295094 Rescue Dossier →